Soliton Stock Forecast, Price & News

Soliton (NASDAQ:SOLY) Frequently Asked Questions

Is Soliton a buy right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Soliton in the last twelve months. There are currently 3 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Soliton stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SOLY, but not buy additional shares or sell existing shares.
View analyst ratings for Soliton or view top-rated stocks.

How has Soliton's stock been impacted by COVID-19?

Soliton's stock was trading at $10.66 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, SOLY shares have increased by 90.6% and is now trading at $20.32.
View which stocks have been most impacted by COVID-19.

When is Soliton's next earnings date?

Soliton is scheduled to release its next quarterly earnings announcement on Thursday, December 9th 2021.
View our earnings forecast for Soliton.

How were Soliton's earnings last quarter?

Soliton, Inc. (NASDAQ:SOLY) issued its quarterly earnings data on Thursday, August, 12th. The company reported ($0.37) earnings per share for the quarter, missing analysts' consensus estimates of ($0.30) by $0.07.
View Soliton's earnings history.

What price target have analysts set for SOLY?

3 brokers have issued 1-year price targets for Soliton's stock. Their forecasts range from $22.60 to $25.00. On average, they anticipate Soliton's stock price to reach $23.80 in the next twelve months. This suggests a possible upside of 17.1% from the stock's current price.
View analysts' price targets for Soliton or view top-rated stocks among Wall Street analysts.

Who are Soliton's key executives?

Soliton's management team includes the following people:

• Bradley A. Hauser, President, Chief Executive Officer & Director
• Joseph D. Tanner, Chief Operating Officer
• Lori Bisson, Chief Financial Officer, Secretary & Executive VP
• Christopher Capelli, Vice Chairman & Chief Science Officer
• Mary Stoll, Senior Director-Clinical Development

Who are some of Soliton's key competitors?

Some companies that are related to Soliton include Silk Road Medical (SILK), Paragon 28 (FNA), Procept BioRobotics (PRCT), Inovio Pharmaceuticals (INO), Atrion (ATRI), Pulmonx (LUNG), OrthoPediatrics (KIDS), Cerus (CERS), Alphatec (ATEC), LeMaitre Vascular (LMAT), Bioventus (BVS), AngioDynamics (ANGO), Sight Sciences (SGHT), Treace Medical Concepts (TMCI) and Intersect ENT (XENT).
View all of SOLY's competitors.

What other stocks do shareholders of Soliton own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Soliton investors own include Cronos Group (CRON), NVIDIA (NVDA), Advanced Micro Devices (AMD), Tesla (TSLA), AbbVie (ABBV), Aurora Cannabis (ACB), (CGC), Micron Technology (MU), Square (SQ) and Verizon Communications (VZ).

What is Soliton's stock symbol?

Soliton trades on the NASDAQ under the ticker symbol "SOLY."

Who are Soliton's major shareholders?

Soliton's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (3.39%), Polar Asset Management Partners Inc. (2.63%), Millennium Management LLC (2.29%), Alpine Associates Management Inc. (1.46%), Candriam Luxembourg S.C.A. (1.11%) and Morgan Stanley (1.07%).
View institutional ownership trends for Soliton.

Which major investors are selling Soliton stock?

SOLY stock was sold by a variety of institutional investors in the last quarter, including Mint Tower Capital Management B.V., Citigroup Inc., Goldman Sachs Group Inc., California State Teachers Retirement System, and Advisor Group Holdings Inc..
View insider buying and selling activity for Soliton or view top insider-selling stocks.

Which major investors are buying Soliton stock?

SOLY stock was bought by a variety of institutional investors in the last quarter, including Millennium Management LLC, Alpine Associates Management Inc., Candriam Luxembourg S.C.A., BlackRock Inc., Marshall Wace LLP, IndexIQ Advisors LLC, Syquant Capital Sas, and Gabelli Funds LLC.
View insider buying and selling activity for Soliton or or view top insider-buying stocks.

How do I buy shares of Soliton?

Shares of SOLY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Soliton's stock price today?

One share of SOLY stock can currently be purchased for approximately $20.32.

How much money does Soliton make?

Soliton has a market capitalization of $438.85 million. The company earns $-14.54 million in net income (profit) each year or ($1.01) on an earnings per share basis.

How many employees does Soliton have?

Soliton employs 14 workers across the globe.

What is Soliton's official website?

The official website for Soliton is www.soliton.com.

Where are Soliton's headquarters?

Soliton is headquartered at 5304 ASHBROOK DRIVE, HOUSTON TX, 77081.

How can I contact Soliton?

Soliton's mailing address is 5304 ASHBROOK DRIVE, HOUSTON TX, 77081. The company can be reached via phone at (844) 705-4866 or via email at [email protected].